Inactive Instrument

News LA JOLLA PHARM Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2022	La Jolla Pharmaceutical Announces Management Changes	CI
2022	La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	25/22/25	PU
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K	22/22/22	PU
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22/22/22	AQ
La Jolla Pharmaceutical Announces Management Changes	22/22/22	CI
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index	22/22/22	CI
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index	22/22/22	CI
Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.	22/22/22	CI
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	15/22/15	AQ
Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.	15/22/15	CI
La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/22/15	CI
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders	28/22/28	BU
Equity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPC	16/22/16	PR
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership (Form 4)	13/22/13	PU
SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company	12/22/12	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News LA JOLLA PHARM Other OTC

Equities

Summary

Filters